Each year, more than 70 million people worldwide suffer a traumatic brain injury or spinal cord injury.
Another 70 million people live daily with neurodegenerative diseases such as Alzheimer’s and Parkinson’s.
 
For most of these patients, no effective treatment exists today.
Neuroplast is working to change that.
 
With Neuro-Cells®, a first-in-class autologous stem cell platform therapy, we aim to restore hope for millions affected by neurodegenerative impairment — by harnessing the body’s own untouched regenerative cells.